Performance Research of Chinese Patent Medicine Enterprises to Innovative Medicine Research and Development Strategy Transformation

Take Zhejiang Conba Pharmaceutical Co., Ltd. as an Example

Abstract

This paper takes the Chinese patent medicine enterprise CONBA as an example, and deeply analyzes the performance of its transformation from traditional Chinese patent medicine to innovative medicine research and development strategy. Through the comparative study of the transformation background, the strategy implementation process and the performance before and after the transformation, the key factors and challenges of its successful transformation are revealed. The research results show that CONBA has successfully realized the strategic transformation from traditional Chinese patent medicine to innovative medicine by increasing r & d investment, optimizing research and development structure and integrating internal and external resources, and achieved significant performance improvement. The research in this paper not only provides practical reference for the strategic transformation of Chinese patent medicine enterprises such as CONBA, but also provides useful reference for the transformation and upgrading of other enterprises.